"mRNA" の関連情報検索結果

mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell e...



mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression  Nature

Rethinking mRNA vaccines: Liver targeting can suppress immunity, while muscle boosts it - Medical...



Rethinking mRNA vaccines: Liver targeting can suppress immunity, while muscle boosts it  Medical Xpress

GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program - Fierce ...



GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program  Fierce Biotech

New Immune Pathway Could Supercharge mRNA Cancer Vaccines - SciTechDaily



New Immune Pathway Could Supercharge mRNA Cancer Vaccines  SciTechDaily

Moderna (MRNA) Q1 2026 Earnings Transcript - The Motley Fool



Moderna (MRNA) Q1 2026 Earnings Transcript  The Motley Fool

Polymarket Earnings: Will CVX, XOM, MRNA Beat Earnings Tomorrow? - TipRanks



Polymarket Earnings: Will CVX, XOM, MRNA Beat Earnings Tomorrow?  TipRanks

Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives Outlook - Se...



Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives Outlook  Seeking Alpha

Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPR - Nature



Translation-dependent degradation of cas12 mRNA triggered by an anti-CRISPR  Nature

A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery - Nature



A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery  Nature

Tuning the immune response to mRNA vaccines - Nature



Tuning the immune response to mRNA vaccines  Nature

Study Overturns Assumption about how mRNA Vaccines Work - Labcompare



Study Overturns Assumption about how mRNA Vaccines Work  Labcompare

Legal settlement drives Q1 2026 loss at Moderna (NASDAQ: MRNA) - Stock Titan



Legal settlement drives Q1 2026 loss at Moderna (NASDAQ: MRNA)  Stock Titan

Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance



Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates  Yahoo Finance

mRNA vaccines follow unconventional immune path to destroy tumors - WashU Medicine



mRNA vaccines follow unconventional immune path to destroy tumors  WashU Medicine

Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Contin...



Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing  Memorial Sloan Kettering Cancer Center

Pancreatic cancer mRNA vaccine shows lasting results in an early trial - NBC News



Pancreatic cancer mRNA vaccine shows lasting results in an early trial  NBC News

Moderna’s Strong Vaccine Sales Outside US Far Surpass Estimates - Bloomberg.com



Moderna’s Strong Vaccine Sales Outside US Far Surpass Estimates  Bloomberg.com

Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars - FinancialContent



Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars  FinancialContent

Moderna, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MRNA) 2026-05-01 - Seeking A...



Moderna, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:MRNA) 2026-05-01  Seeking Alpha

[144] Moderna, Inc. SEC Filing - Stock Titan



[144] Moderna, Inc. SEC Filing  Stock Titan

Moderna stock jumps after Q1 2026 beat (MRNA:NASDAQ) - Seeking Alpha



Moderna stock jumps after Q1 2026 beat (MRNA:NASDAQ)  Seeking Alpha

Rare myocarditis after mRNA vaccination: Mitochondrial stress identified as a key factor - Medica...



Rare myocarditis after mRNA vaccination: Mitochondrial stress identified as a key factor  Medical Xpress

EU clears Moderna's flu-COVID shot as Q1 loss hits $1.3B - Stock Titan



EU clears Moderna's flu-COVID shot as Q1 loss hits $1.3B  Stock Titan

Engineered cells as programmable mRNA delivery vehicles - Nature



Engineered cells as programmable mRNA delivery vehicles  Nature

mRNA vaccines engage unconventional pathways in CD8+ T cell priming - Nature



mRNA vaccines engage unconventional pathways in CD8+ T cell priming  Nature

After a year of turmoil, cancer researchers see promising signs for mRNA vaccines - CNN



After a year of turmoil, cancer researchers see promising signs for mRNA vaccines  CNN

Moderna (NASDAQ: MRNA) grows Q1 2026 revenue but books $1.3B loss - Stock Titan



Moderna (NASDAQ: MRNA) grows Q1 2026 revenue but books $1.3B loss  Stock Titan

Moderna Inc (NASDAQ:MRNA) Surges Past Q1 Estimates on International Strength - ChartMill



Moderna Inc (NASDAQ:MRNA) Surges Past Q1 Estimates on International Strength  ChartMill

MRNA Stock Rises Pre-Market: Moderna Bets On US Comeback With Flu Vaccine Pipeline - Stocktwits



MRNA Stock Rises Pre-Market: Moderna Bets On US Comeback With Flu Vaccine Pipeline  Stocktwits

Moderna: Q1 Earnings Snapshot - KING5.com



Moderna: Q1 Earnings Snapshot  KING5.com

Why Is Moderna Stock Falling Friday? - Moderna (NASDAQ:MRNA) - Benzinga



Why Is Moderna Stock Falling Friday? - Moderna (NASDAQ:MRNA)  Benzinga

Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Stree...



Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimat  The Economic Times

New mRNA Therapy Uses Red Blood Cells to Attack Tumours from Within - The Indian Practitioner



New mRNA Therapy Uses Red Blood Cells to Attack Tumours from Within  The Indian Practitioner

mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive datase...



mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset  Nature

Moderna (MRNA): 10 Best Performing S&P 500 Stocks So Far in 2026 - Yahoo Finance



Moderna (MRNA): 10 Best Performing S&P 500 Stocks So Far in 2026  Yahoo Finance

Moderna (MRNA) Reports Earnings Tomorrow: What To Expect - StockStory



Moderna (MRNA) Reports Earnings Tomorrow: What To Expect  StockStory

Laguna Diagnostics mRNA Gene Biomarker Test Gets FDA Breakthrough Device Status - Contract Pharma



Laguna Diagnostics mRNA Gene Biomarker Test Gets FDA Breakthrough Device Status  Contract Pharma

Expanding global access to mRNA vaccines - Nature



Expanding global access to mRNA vaccines  Nature

Malaria parasite sneaks mRNA into immune cell nuclei, disrupting defenses - Phys.org



Malaria parasite sneaks mRNA into immune cell nuclei, disrupting defenses  Phys.org

Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat breast cancer - Nature



Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat breast cancer  Nature

Moderna Q1 preview: revenue rebound in focus as losses persist (MRNA:NASDAQ) - Seeking Alpha



Moderna Q1 preview: revenue rebound in focus as losses persist (MRNA:NASDAQ)  Seeking Alpha

NFID Statement on mRNA Technology - National Foundation for Infectious Diseases



NFID Statement on mRNA Technology  National Foundation for Infectious Diseases

Comparative study of analytical methods for assessing mRNA integrity and identification of functi...



Comparative study of analytical methods for assessing mRNA integrity and identification of functional mRNA oligomers  Nature

ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy - UT MD Anderson



ESMO 2025: mRNA-based COVID vaccines generate improved responses to immunotherapy  UT MD Anderson

European regulators recommend approval of combined mRNA vaccine for flu and COVID - CIDRAP



European regulators recommend approval of combined mRNA vaccine for flu and COVID  CIDRAP

Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine - The New England Journal...



Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine  The New England Journal of Medicine

Why you should keep getting mRNA vaccines - Scientific American



Why you should keep getting mRNA vaccines  Scientific American

HHS Winds Down mRNA Vaccine Development Under BARDA - HHS.gov



HHS Winds Down mRNA Vaccine Development Under BARDA  HHS.gov

Earnings Flash (MRNA) Moderna Posts Q1 Loss $3.40 a Share, vs. FactSet Est of $4.45 Loss - market...



Earnings Flash (MRNA) Moderna Posts Q1 Loss $3.40 a Share, vs. FactSet Est of $4.45 Loss  marketscreener.com

New report sounds alarm on health fallout from mRNA vaccine funding cuts - Yale School of Public ...



New report sounds alarm on health fallout from mRNA vaccine funding cuts  Yale School of Public Health

How a rapid-response bird flu vaccine trial is shaping global preparedness - Gavi, the Vaccine Al...



How a rapid-response bird flu vaccine trial is shaping global preparedness  Gavi, the Vaccine Alliance

Earnings Flash (MRNA) Moderna, Inc. Reports Q1 Revenue $389.0M, vs. FactSet Est of $236.4M - mark...



Earnings Flash (MRNA) Moderna, Inc. Reports Q1 Revenue $389.0M, vs. FactSet Est of $236.4M  marketscreener.com

Scientists Develop a Smarter mRNA Therapy That Knows Which Cells to Target - Mount Sinai



Scientists Develop a Smarter mRNA Therapy That Knows Which Cells to Target  Mount Sinai

How mRNA Vaccines Can Help Fight Cancer - Ground Truths | Eric Topol



How mRNA Vaccines Can Help Fight Cancer  Ground Truths | Eric Topol

An mRNA influenza vaccine induces immunity comparable to an adjuvanted vaccine in a randomized tr...



An mRNA influenza vaccine induces immunity comparable to an adjuvanted vaccine in a randomized trial  Nature

Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer - UF...



Media Coverage of Study Finding COVID-19 mRNA Vaccine Sparks Immune Response to Fight Cancer  UF Health

Moderna says FDA will now consider its new mRNA flu shot after initial refusal - PBS



Moderna says FDA will now consider its new mRNA flu shot after initial refusal  PBS

Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue - StreetInsider



Moderna (MRNA) Misses Q1 EPS by $1.38, Beats on Revenue  StreetInsider

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature



Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC  Nature

Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next - Nature



Breaking barriers in prostate cancer: the mRNA vaccine breakthrough and what comes next  Nature

mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma - Nature



mRNA vaccine developed for sequential selective organ-to-cell targeting of glioma  Nature

Moderna developed an mRNA Covid-flu combo vaccine and it’s b... - Kottke.org



Moderna developed an mRNA Covid-flu combo vaccine and it’s b...  Kottke.org

Global landscape of mRNA vaccine clinical trials: a systematic analysis of ClinicalTrials.gov dat...



Global landscape of mRNA vaccine clinical trials: a systematic analysis of ClinicalTrials.gov data  Frontiers

MRNA Vaccine Misinformation Threatens Cancer Treatment Breakthroughs - FlaglerLive



MRNA Vaccine Misinformation Threatens Cancer Treatment Breakthroughs  FlaglerLive

Why mRNA is important for U.S. national security - Hopkins Bloomberg Center



Why mRNA is important for U.S. national security  Hopkins Bloomberg Center

Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation ...



Mechanisms linking cytoplasmic decay of translation-defective mRNA to transcriptional adaptation  Science | AAAS

Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA s...



Loop structure in poly(A) tail of mRNA vaccine enhances antigen translation efficiency and mRNA stability  Nature

Association of mRNA COVID-19 vaccination with overall survival in patients receiving immune check...



Association of mRNA COVID-19 vaccination with overall survival in patients receiving immune checkpoint inhibitors: a retrospective cohort analysis  medRxiv

Moderna loses key mRNA patent in European vaccine fight - Life Sciences Intellectual Property Review



Moderna loses key mRNA patent in European vaccine fight  Life Sciences Intellectual Property Review

Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine - CIDRAP



Sanofi scraps plan to develop next-generation mRNA seasonal flu vaccine  CIDRAP

Is Moderna (MRNA) Pricing Make Sense After 77% One-Year Surge And DCF Signal? - Yahoo Finance



Is Moderna (MRNA) Pricing Make Sense After 77% One-Year Surge And DCF Signal?  Yahoo Finance

Deep generative models design mRNA sequences with enhanced translational capacity and stability -...



Deep generative models design mRNA sequences with enhanced translational capacity and stability  Science | AAAS

Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve im...



Metabolism-programming mRNA-lipid nanoparticles remodel the immune microenvironment to improve immunotherapy against MAFLD  Science | AAAS

U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says - PBS



U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says  PBS

People with some cancers live longer after a COVID vaccine - Nature



People with some cancers live longer after a COVID vaccine  Nature

Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines...



Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines threatens their potential  The Conversation

The Prevalence and Policy Consequences of "mRNA Vaccine Stigmatization" in the US - Harvard T.H. ...



The Prevalence and Policy Consequences of "mRNA Vaccine Stigmatization" in the US  Harvard T.H. Chan School of Public Health

‘Type’ Casting: Flagship-Founded Serif Modifying DNA into New Therapy Class - Genetic Engineering...



‘Type’ Casting: Flagship-Founded Serif Modifying DNA into New Therapy Class  Genetic Engineering and Biotechnology News

Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines - ...



Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines  Nature

SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade - Nature



SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade  Nature

CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate - CEPI



CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate  CEPI

Purdue mRNA therapy delivery system proves to be shelf-stable, storable - Purdue University



Purdue mRNA therapy delivery system proves to be shelf-stable, storable  Purdue University

Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody...



Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice  Science | AAAS

Sinergium paves the way for Latin American mRNA vaccines with new preclinical study - CEPI



Sinergium paves the way for Latin American mRNA vaccines with new preclinical study  CEPI

Understanding the Impact of Federal Cuts to mRNA Vaccine Research - American Lung Association



Understanding the Impact of Federal Cuts to mRNA Vaccine Research  American Lung Association

Slashing of funding for mRNA vaccine development raises concern - Harvard T.H. Chan School of Pub...



Slashing of funding for mRNA vaccine development raises concern  Harvard T.H. Chan School of Public Health

Moderna’s H5N1 Vaccine Trial Draws Support As Valuation Stays Stretched - simplywall.st



Moderna’s H5N1 Vaccine Trial Draws Support As Valuation Stays Stretched  simplywall.st

mRNA initiation and termination are spatially coordinated - Science | AAAS



mRNA initiation and termination are spatially coordinated  Science | AAAS

Could mRNA vaccines end brutal flu seasons? - Gavi, the Vaccine Alliance



Could mRNA vaccines end brutal flu seasons?  Gavi, the Vaccine Alliance

Could COVID-19 mRNA vaccines help treat cancer? - Oncology Central



Could COVID-19 mRNA vaccines help treat cancer?  Oncology Central

FDA reverses course on Moderna flu shot - NPR



FDA reverses course on Moderna flu shot  NPR

Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus - CEPI



Scientists in Korea to create mRNA vaccine against emerging Asian tick-borne virus  CEPI

US vaccine panel retreats from mRNA Covid review ahead of midterms | Trump administration - The G...



US vaccine panel retreats from mRNA Covid review ahead of midterms | Trump administration  The Guardian

A New Flu Shot May Boost Protection for Older Adults - AARP



A New Flu Shot May Boost Protection for Older Adults  AARP

Answering common questions on mRNA technology - PhRMA



Answering common questions on mRNA technology  PhRMA

Vanguard Capital Management (MRNA) reports 25.9M-share stake (6.53%) - Stock Titan



Vanguard Capital Management (MRNA) reports 25.9M-share stake (6.53%)  Stock Titan

mRNA-Based COVID Vaccines May Generate Improved Responses to Immunotherapy - The ASCO Post



mRNA-Based COVID Vaccines May Generate Improved Responses to Immunotherapy  The ASCO Post

Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer - UF Health



Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer  UF Health

Spatially regulated mRNA translation enables functional membrane protein integration in synthetic...



Spatially regulated mRNA translation enables functional membrane protein integration in synthetic cells  PNAS

How fast mRNA degrades linked to autoimmune disease risk - Newsroom | UCLA



How fast mRNA degrades linked to autoimmune disease risk  Newsroom | UCLA